FindMyKOL
Clinical trialNCT01133535CompletedObservational

Idiopathic Recurrent Acute Pancreatitis (IRAP)

NCT01133535 is an observational study sponsored by Wake Forest University Health Sciences. As of 21 Nov 2026, it is completed. It studies Pancreatitis. The registry lists an enrollment of 50 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2010 and a primary completion date of 31 Dec 2013.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01133535
FieldValue
Registry IDNCT01133535
StatusCompleted
Study typeObservational study
Lead sponsorWake Forest University Health Sciences
Enrollment50
Registered sites1
Countries1
ConditionsPancreatitis
Start30 Jun 2010
Primary completion31 Dec 2013
Study completion30 Apr 2014
Last update posted3 Oct 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to collect standardized data on the diagnosis and management of idiopathic (unknown cause) recurrent acute pancreatitis. The intent is to collect data for at least five years to obtain information regarding long-term outcomes and obtain comparative effectiveness data.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Wisconsin, United States1 site
  • Aurora St. Lukes Medical Center of Aurora Health Care

    Milwaukee

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsin: 1 siteWI1MichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01133535

Each answer restates registry values shown on this page.

What is NCT01133535?

NCT01133535 is an observational study sponsored by Wake Forest University Health Sciences. It studies Pancreatitis.

Who leads NCT01133535?

The registry names Nalini M Guda, MD (principal investigator, Wake Forest University Health Sciences) as the overall official.

Where does NCT01133535 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01133535 end?

The registry lists a primary completion date of 31 Dec 2013 and a study completion date of 30 Apr 2014. The sponsor last updated the record on 3 Oct 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.